Results 31 to 40 of about 13,840,459 (217)

Brolucizumab-induced retinal vasculitis – An Indian perspective

Indian Journal of Ophthalmology. Case Reports, 2022
The case of retinal vasculitis in a one-eyed elderly diabetic female after use of brolucizumab injection (second dose) for neovascular age-related macular degeneration.
Manpreet Brar, Mangat R Dogra, SPS Grewal, Mansi Sharma, Dilraj Grewal   +4 more
doaj   +1 more source

Macular Neovascularization in Neovascular Age-Related Macular Degeneration

Ophthalmology Retina
Topic This systematic review evaluates the methodologies used for assessing the macular neovascularization (MNV) in neovascular age-related macular degeneration (nAMD) using OCT angiography (OCTA). It focuses on identifying methodological heterogeneity in imaging and analysis protocols and its implications for clinical and research applications ...
Novarese, Cristina, Vyas, Chinmayi, Berni, Alessandro, Bacherini, Daniela, Chaudhary, Varun, Dolz-Marco, Rosa, Gallego-Pinazo, Roberto, Mastropasqua, Rodolfo, Reiter, Gregor S., Subhi, Yousif, Bandello, Francesco, Reibaldi, Michele, Borrelli, Enrico   +12 more
openaire   +1 more source

New Therapies of Neovascular AMD beyond Anti-VEGF Injections

Vision, 2018
Neovascular age-related macular degeneration is a leading cause of vision loss among the aging population. The current standard of care to treat neovascular age-related macular degeneration is inhibiting vascular endothelial growth factor (VEGF) through ...
Greggory M. Gahn, Arshad M. Khanani
doaj   +1 more source

Unusual visual loss in a patient with exudative macular degeneration

American Journal of Ophthalmology Case Reports, 2022
Purpose: To describe a case of marked vision loss in a patient with neovascular age-related macular degeneration after choroidal neovascular membrane (CNV) improvement and stabilization.
Enoch T. Peng, Sean D. Adrean
doaj   +1 more source

The association between neovascular age-related macular degeneration and regulatory T cells in peripheral blood

, 2015
Christopher Fugl Madelung,1,2 Mads Krüger Falk,1,2 Torben Lykke Sørensen1,2 1Clinical Eye Research Unit, Department of Ophthalmology, Copenhagen University Hospital, Roskilde, Denmark; 2University of Copenhagen, Copenhagen, Denmark ...
Sørensen, Torben Lykke, Falk, Mads, Madelung CF, Falk MK, Sørensen TL, Madelung, Christopher Fugl   +5 more
core   +1 more source

CFH, C3 and ARMS2 are significant risk loci for susceptibility but not for disease progression of geographic atrophy due to AMD. [PDF]

, 2009
Age-related macular degeneration (AMD) is a prevalent cause of blindness in Western societies. Variants in the genes encoding complement factor H (CFH), complement component 3 (C3) and age-related maculopathy susceptibility 2 (ARMS2) have repeatedly been
Weber, Bernhard H. F., Fleckenstein, Monika, Frank G Holz, Weber, B. H., Hendrik P N Scholl, Scholl, Hendrik P. N., Tim Becker, Ulrich Mansmann, Weinberger Andreas W. A., Schmitz-Valckenberg Steffen, Mackensen, F., Herold Christine, Holz, Frank G, Scholl Hendrik P. N., Weber, Bernhard H F, Andreas Mössner, Keilhauer, Claudia N, Scholl, Hendrik P N, Fritsche, Lars G., Steffen Schmitz-Valckenberg, Schmitz-Valckenberg, S., Claudia N Keilhauer, Weinberger, A. W., Fritsche, Lars G, Weinberger, Andreas W. A., Pauleikhoff, D., Becker, T., Andreas W A Weinberger, Adrion, Christine, Mansmann Ulrich, Weber Bernhard H. F., Becker Tim, Göbel, Arno, Mackensen Friederike, Holz, F. G., Monika Fleckenstein, Göbel, A., Adrion Christine, Holz Frank G., Scholl, H. P., Friederike Mackensen, Mackensen, Friederike, Mansmann, Ulrich, Göbel Arno, Becker, Tim, Fleckenstein Monika, Mössner, Andreas, Lars G Fritsche, Fritsche Lars G., Keilhauer Claudia N., Schmitz-Valckenberg, Steffen, Fritsche, L. G., Herold, Christine, Arno Göbel, Daniel Pauleikhoff, Weinberger, Andreas, Christine Herold, Mansmann, U., Christine Adrion, Bernhard H F Weber, Mössner, A., Pauleikhoff, Daniel, Keilhauer, C. N., Herold, C., Holz, Frank G., Adrion, C., Mößner Andreas, Pauleikhoff Daniel, Fleckenstein, M.   +68 more
core   +2 more sources

Management of neovascular age-related macular degeneration: current state-of-the-art care for optimizing visual outcomes and therapies in development [PDF]

, 2015
Contemporary management of neovascular age-related macular degeneration (AMD) has evolved significantly over the last few years. The goal of treatment is shifting from merely salvaging vision to maintaining a high quality of life.
Hanout, Mostafa, Sadiq, Mohammad A., Sepah, Yasir J., Dong Nguyen, Quan, Rhoades, William R., Agarwal, Aniruddha, Sarwar, Salman, Do, Diana V., Soliman, Mohamed Kamel K., Nguyen QD, Sadiq MA, Rhoades WR, Soliman MK, Sepah YJ, Agarwal A, Sarwar S, Do DV, Hanout M   +17 more
core   +2 more sources

The Multiple Criteria Qualitative Value‐Based Pricing Framework “MARIE” for Novel Cell and Gene Therapy

Clinical Pharmacology &Therapeutics, EarlyView.
When setting the price of cell and gene therapies in Japan, the factors considered include the manufacturing and operating costs of the new drug or a comparator, leading to discrepancies between price and values, in particular those specific to cell and gene therapies.
Akina Takami, Ataru Igarashi
wiley   +1 more source

Age-related macular degeneration in the UK [PDF]

The aim of this thesis was to investigate the prevalence and impact of age-related macular degeneration (AMD) causing visual impairment in people aged 75 years and above in the UK.
Evans, Jennifer Rosemary
core   +1 more source

Evaluation of Flowmetry Indicators in Patients with a Wet AMD Form during Antiangiogenic Therapy

Oftalʹmologiâ, 2019
Purpose: to assess the effect of aflibercept (Eylea; “Regeneron”, USA) intravitreal injections on ocular blood flow and intraocular pressure parameters in patients with neovascular form of age-related macular degeneration (wet AMD).
N. Yu. Yousef, E. E. Kazaryan, D. M. Safonova, N. Yu. Shkolyarenko, F. B. Dudieva, T. V. Sharnina   +5 more
doaj   +1 more source